Odyssean »

Vici Pptys shares owned by Odyssean

Quarter-by-quarter ownership of Vici Pptys (VICI) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Vici Pptys

Tip: Access up to 7 years of quarterly data

All positions including Vici Pptys held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vici Pptys by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $236k 8.9k 26.55

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Vici Pptys

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Allianz Asset Management
Bank of America Corporation
Jpmorgan Chase & Co
T. Rowe Price Associates
Capital Research Global Investors
Invesco
Dimensional Fund Advisors
Northern Trust
Charles Schwab Investment Management
Legal & General Group

View all funds holding Vici Pptys